We have recently demonstrated that inhibition of S1P receptors with the functional antagonist FTY720 (fingolimod/gilenya) inhibits HIV-1 infection of primary CD4 T cells by multiple mechanisms. This evidence concerns the gene CD4 and HIV-1 infection.